Dexamethasone
-
Central Government Allows Covid-19 Low Cost Medicine Dexamethasone for Use in India
The Central government has approved the usage of low-cost steroid drug dexamethasone to treat the covid-19 patients in India with moderate and severe symptoms. British clinical trials had earlier found Dexamethasone to be effective against severely ill patients. The drug is approved to be used…
#Top on Krishi Jagran
We're on WhatsApp! Join our WhatsApp group and get the most important updates you need. Daily.
Join on WhatsAppSubscribe to our Newsletter. You choose the topics of your interest and we'll send you handpicked news and latest updates based on your choice.
Subscribe NewslettersLatest feeds
- Pusa Krishi, ICAR-IARI Successfully Hosts SAMARTH 2026 – Empowering the Incubators
- Supply Disruptions, Cost Surge and Risk of Counterfeits: CropLife India Sounds Alarm
- "New Technologies crucial for Sustainable Nutrition”, aver experts during AMIFOST – 2026, at Amity
- Debunking Pesticide Myths: CropLife India Calls for Evidence-Based Debate on Crop Protection
- PM-KISAN Samman Nidhi: Role of Direct Income Support in Strengthening Farm Households
- DSR can reduce water use by up to 35% and cut cultivation costs by ₹14,000/ha; FSII calls for wider adoption
- New Delhi to Host Ground-breaking Global Conference on Women in Agri-Food Systems (GCWAS–2026)
- Cargill Highlights Scalable, Market-Ready Innovations under the theme of ‘Your Possibilities, Our Purpose’ at AAHAR 2026
- The Invisible Workforce: Women Behind India’s Farms
- Story of a Woman Farmer from Rudraprayag Whose Determination Restored Land and Livelihoods